Zoeken | AC Mingle

akanksha9229 toegevoegd een audio Other
2026-05-21 12:06:28 -

Biosimilars and Follow-on Biologics Market to 2035 | USD 145.2B Growth at 14.1% CAGR
The global Biosimilars and Follow-on Biologics Market is witnessing rapid expansion, with market value estimated at USD 38.7 billion in 2025 and projected to reach USD 145.2 billion by 2035, growing at a CAGR of 14.1% during the forecast period. Growth is being driven by rising demand for cost-effective biologic therapies, increasing patent expirations of blockbuster biologic drugs, expanding...

0 Reacties 0 aandelen 600 Views 0 voorbeeld

Please log in to like, share and comment!
pratap11 toegevoegd een audio Other
2026-10-22 11:55:48 -

Biosimilars Market: How Affordable Biologics Are Expanding Access to Advanced Treatments
Biosimilars Market: Interchangeability, Patent Expiry and the Checkpoint Inhibitor Pipeline The Biosimilars Market comprises biological medicines shown to be highly similar to an already approved reference biologic, with no clinically meaningful differences in safety, purity or potency. In the US, they are approved through the abbreviated 351(k) pathway established under the Biologics Price...

0 Reacties 0 aandelen 53 Views 0 voorbeeld

Please log in to like, share and comment!
PolarisNews toegevoegd een audio Art
2026-09-21 14:31:55 -

Herceptin Biosimilars Market to Reach USD 21,271.43 Million by 2034, Growing at 22.9% CAGR
The Herceptin Biosimilars Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Herceptin Biosimilars Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future potential to...

0 Reacties 0 aandelen 172 Views 0 voorbeeld

Please log in to like, share and comment!
PolarisNews toegevoegd een audio Art
2026-10-05 14:26:51 -

Partnerships and Licensing Deals Are Expanding the Biosimilars Market Globally
Biosimilars Market to Reach USD 73.24 Billion by 2036: What Is Driving Growth Healthcare systems around the world are under pressure to deliver advanced therapies at lower cost. Biologic medicines treat cancer, autoimmune disorders, and eye diseases, but their high prices strain budgets. This is where the Biosimilars Market is making a real difference. By offering highly similar alternatives to...

0 Reacties 0 aandelen 143 Views 0 voorbeeld

Please log in to like, share and comment!